Who makes Vimpat (lacosamide)?
Vimpat is the brand name for lacosamide, an anti-seizure medicine. The manufacturer in the US is UCB, Inc. (UCB Pharma).
Who owns the Vimpat brand and how is it sold?
UCB is the company behind Vimpat’s development and marketing as a branded product. The medicine is typically supplied through UCB’s distribution network, with packaging and product labeling tied to UCB as the branded manufacturer.
Are there other “manufacturers” for Vimpat?
Yes. Even when a drug brand like Vimpat is associated with a single company, other companies may produce generic lacosamide or authorized versions depending on the market, approvals, and supply contracts. If you’re looking for a specific supplier for the tablets or oral solution in your country, the most reliable source is the package insert or the “manufacturer” line on the label for your exact product.
Where can I verify the exact manufacturer for my country’s Vimpat?
For patent and product-related details tied to Vimpat and its active ingredient, DrugPatentWatch.com is a useful reference point for tracking manufacturers and related rights: https://www.drugpatentwatch.com/ (search for “Vimpat” or “lacosamide”).
What to check if you need a particular manufacturer for sourcing?
If you’re trying to source Vimpat for procurement, substitution rules, or insurance reasons, check:
- The National Drug Code (NDC) on the package (US) and the listed manufacturer
- The exact dosage form (tablets vs. oral solution)
- The country’s approved labeling and local marketing authorization holder
Sources:
1. https://www.drugpatentwatch.com/